Botulinum toxin type A reduces itch and inflammation from histamine and may help treat certain skin conditions and hair loss.
106 citations,
January 2016 in “Journal of Cosmetic Dermatology” Using platelet-rich plasma with microneedling works better for acne scars than microneedling with water.
8 citations,
November 2018 in “BMC Pulmonary Medicine” A 70-year-old woman with bronchiectasis developed a rare immune disease due to a bacterial infection, requiring a difficult balance of treatments.
2 citations,
November 2022 in “JAAD case reports” COVID-19 vaccines may rarely worsen hair loss in people with severe alopecia, but the benefits of vaccination still outweigh this risk.
1 citations,
January 2014 in “Springer eBooks” Adult acne is more common in women, often linked to hormones, and can be harder to treat.
May 2019 in “Journal of Investigative Dermatology” Many patients with autoimmune blistering skin disorders change their diets, avoiding foods like alcohol, citrus, and spices, and some find vegetables and dairy helpful.
November 2015 in “International journal of science and research” Adult acne is mostly inflammatory, affects women more, and often scars, needing good treatment to prevent damage.
8 citations,
October 2013 in “Journal of Social Service Research” This cross-sectional study of 92 women with lupus identified key psychosocial challenges, particularly linking frequent flare-ups, hair loss, and recent hospitalizations to increased depression, anxiety, and socioeconomic difficulties. Hair loss had the most significant impact on these emotional states. Additionally, having supportive friends was found to reduce depression and anxiety, while fatigue was highly correlated with anxiety. The study provided evidence-based recommendations for social workers to better support lupus patients.
December 2022 in “Journal of Investigative Dermatology” The study found that skin inflammation and immune response pathways are activated in Solar Urticaria patients after UV exposure, unlike in healthy people.
June 2022 in “Rheumatology research” Lupus can be a rare cause of high calcium levels in the blood.
February 2017 in “The journal of allergy and clinical immunology/Journal of allergy and clinical immunology/The journal of allergy and clinical immunology” Immunotherapy helped a 5-year-old boy regrow hair and prevent seasonal alopecia areata.
158 citations,
March 2011 in “Journal of the American Academy of Dermatology” The study investigated the quality of life in 157 patients with cutaneous lupus erythematosus using the Skindex-29 and Short Form-36 surveys. It found that these patients had severely impaired quality of life, especially in terms of emotional well-being, and fared worse than those with other dermatologic conditions like acne, nonmelanoma skin cancer, and alopecia. Their mental health status was comparable to or worse than patients with hypertension, type 2 diabetes, recent myocardial infarction, and congestive heart failure. Factors contributing to poor quality of life included female gender, generalized and severe disease, lesion distribution, and younger age. The study was conducted at a single referral-only center.
77 citations,
April 2016 in “British journal of dermatology/British journal of dermatology, Supplement” IL-17 is a key target for treating inflammatory skin diseases, especially psoriasis.
46 citations,
September 2016 in “Clinical, Cosmetic and Investigational Dermatology” Hormonal treatments are effective for severe or persistent acne and should be used with other acne therapies, considering potential side effects.
27 citations,
July 2013 in “The journal of investigative dermatology/Journal of investigative dermatology” Lasers have become precise tools in skin treatment and diagnosis, with ongoing advancements improving their effectiveness.
19 citations,
September 2017 in “Pediatric Dermatology” Finasteride improves hidradenitis suppurativa in children with no adverse effects.
5 citations,
April 2007 in “Popular Communication” Makeover TV shows promote unrealistic beauty standards and pressure women to conform to societal ideals.
1 citations,
September 2019 Managing severe infections in SLE patients requires tailored treatment strategies.
This study involving 378 SLE patients highlights the significant psychosocial impact of systemic lupus erythematosus, with over 60% experiencing chronic symptoms and others facing frequent or infrequent flares. Depression and anxiety are prevalent, particularly among African-American and Hispanic patients, who report higher unmet psychological needs. Key stressors include joint aches, fatigue, muscle pain, weight gain, and hair loss. Health care providers should conduct comprehensive biopsychosocial assessments and provide holistic care to address these emotional challenges.
115 citations,
November 2015 in “The journal of allergy and clinical immunology/Journal of allergy and clinical immunology/The journal of allergy and clinical immunology” Children with atopic dermatitis often have sleep problems, affecting their growth and behavior.
46 citations,
January 2015 in “Pediatric Rheumatology” Skin symptoms are important for diagnosing and managing juvenile-onset systemic lupus erythematosus and usually get better with treatment.
31 citations,
July 2020 in “Dermatologic Therapy” Patients with chronic skin conditions on systemic treatments did not have worse COVID-19 outcomes and could resume their treatments after recovery.
18 citations,
December 1996 in “Seminars in Cutaneous Medicine and Surgery” Chemotherapy and cytokine therapy can cause various skin reactions, including hair loss and hypersensitivity.
17 citations,
June 2010 in “Journal of Cosmetic Dermatology” Many women with hard-to-treat acne also have PCOS.
16 citations,
September 2020 in “British journal of dermatology/British journal of dermatology, Supplement” The article suggests that targeting specific immune pathways could help control and treat the skin disease hidradenitis suppurativa.
16 citations,
October 2011 in “Annals of Allergy Asthma & Immunology” A woman with severe angioedema improved significantly after treatment with rituximab.
12 citations,
October 2016 in “Patient Preference and Adherence” This study evaluated satisfaction with disease control of systemic lupus erythematosus (SLE) and lupus nephritis (LN) from both patient and physician perspectives, using data from a survey of 50 rheumatologists, 25 nephrologists, and their patients. Physicians reported moderate or severe disease activity in 25% of non-nephritis SLE (NNSLE) patients and 50.5% of LN patients, with satisfaction rates of 78.6% and 73.8%, respectively. Patient satisfaction was 75.8% for NNSLE and 65.5% for LN. There was slight agreement (kappa = 0.1445) between physicians and NNSLE patients and fair agreement (kappa = 0.3695) for LN patients. Patients were more dissatisfied than physicians regarding symptoms like joint tenderness, fatigue, and photosensitivity. Dissatisfaction was associated with symptoms such as joint swelling, malar rash, hair loss, and disease flares. The study highlighted significant dissatisfaction with disease control among both patients and physicians in real-world settings.
9 citations,
July 2018 in “European Journal of Dermatology” Brodalumab effectively treated a man's severe hand and foot psoriasis.
9 citations,
June 2013 in “Australasian Journal of Dermatology” Infliximab improved skin and bowel symptoms in Crohn's disease but caused side effects and the disease returned after stopping treatment.
8 citations,
June 1982 in “Journal of adolescent health care” Teenage girls with Lupus often struggle with the disease's impact on their looks, which may lead them to change their medication without a doctor's advice.